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Summanr Epidermal growth factor (EGF) mediates many pleiotrophic biological effects, one of which is
alteration of cellular morphology. In the present study. we examine the possibility that this alteration in cell
morphology is caused in part by the dysfunction of cadherin-mediated cell-cell adhesion using the human
oesophageal cancer cell line TE-2R. which expresses E-cadherin and EGF receptor. In the presence of EGF.
TE-2R changed its shape from round to fibroblastic and its colony formation from compact to sparse.
Vanadate. a tyrosine phosphatase inhibitor, further potentiated the EGF response. whereas herbimycin A. a
tvrosine kinase inhibitor, interfered with it. Moreover. EGF enabled the cells to invade in organotypic raft
culture. These phenomena were accompanied not by decreased expression of the E-cadherin molecule but by a
change in its localisation from the lateral adhesion site to the whole cell surface. Both a- and P-catenin.
cadherin-binding proteins, were also expressed at the same level throughout these morphological changes.
Finally. we examined tyrosine phosphorylation of E-cadherin and a- and P-catenin. and observed tyrosine
phosphorylation of -catenin induced by EGF. These results suggest that EGF counteracts E-cadherin-
mediated junctional assembly through phosphorylation ofP-catenin and modulates tumour cell behaviour to a
more aggressive phenotype.
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Amplification of the epidermal growth factor receptor
(EGFR) gene and consequent overexpression of EGFR have
been observed in human carcinomas in vivo (Sainsbury et al.,
1985; Malden et al., 1988; Yoshida et al., 1989). In patients
with squamous cell carcinomas of the oesophagus, we have
previously demonstrated that overexpression of both EGFR
and its ligand, transforming growth factor a (TGF-a), is
associated with poor clinical outcome (lihara et al., 1993).
Interestingly, overexpression of TGF-acEGFR is correlated
more strongly with metastasis and invasion than with tumour
size. EGFR transmits a mitogenic signal through its tyrosine
kinase activity. However, activation of EGFR also influences
a number of other phenotypic properties in malignant cells in
vitro, including cell motility stimulation (Lund-Johansen et
al., 1990) and matrix protease production (Boyd. 1989; Nied-
bala and Sartorelli. 1989). Consequently, acceleration of cell
motility and proteolysis is considered to cause invasion when
EGFR is activated. On the other hand, we have demon-
strated that intercellular adhesion mediated by E-cadherin is
another major factor which restricts cell invasion and metas-
tasis (Doki et al., 1993: Oka et al.. 1993). Therefore, in this
study, we explore the possibility that EGF EGFR perturbs
the E-cadherin adhesion system and might consequently
induce tumour invasion.
Cell-cell adhesion is mainly regulated by homotypic inter-
action of cadhenrn molecules, which are anchored to the
cytoskeleton via associated cytoplasmic proteins, such as a-
and -catenin (Nagafuchi and Takeichi, 1988; Ozawa et al.,
1989) and the 220 kDa protein (Itoh et al., 1991). Thus,
cadherin-mediated cell adhesion is composed of many com-
ponents and could be disrupted in a variety of ways. Three
mechanisms of alteration of the cadherin mediated cell-cell
adhesion system have been described in human cancer in vivo
and in vitro. The first is down-regulation of cadherin expres-
sion (Behrens et al., 1989; Frixen et al.. 1991) and the second
is deletion of a-catenin (Shimoyama et al.. 1992). In the case
of oesophageal cancer. reduced expression of either E-cad-
hemn or a-catenin has been detected in 80% of tumours
(Kadowaki et al.. 1994). The third abnormality of this
adhesion system is biochemical modification of catenins.
Tyrosine phosphorylation of catenins suppresses cadherin
function in vitro (Matsuyoshi et al., 1992: Behrens et al.,
1993; Hamaguchi et al.. 1993). Since, in these experiments,
tyrosine phosphorylation was induced by v-Src. a non-
receptor type tyrosine kinase. it would be interesting to
analyse the effect of receptor tyrosine kinase activation on
E-cadherin-mediated cell-cell adhesion.
In this study. we used TE-2R cells, an E-cadherin-positive
clone from human oesophageal cancer TE-2 (Doki et al..
1993). and found alteration of cell morphology and adhesive-
ness in the presence of EGF. which is accompanied by
tyrosine phosphorylation of -catenin. These results are des-
cribed and the possible action of EGF EGFR in cell adhe-
sion and invasion is demonstrated.
Materials and methods
Cell culture
TE-2R and TE-2S were cloned by the limiting dilution
method from TE-2. a poorly differentiated squamous cell
carcinoma of the human oesophagus (kindly provided by Dr
Nishihira, University of Tohoku, Japan). as previously des-
cribed (Doki et al., 1993). Cells were maintained in a 1:1
mixture of Dulbecco's modified Eagle medium and Ham's
F12 medium supplemented with 5% fetal calf serum
(DH5).
Antibodies and growthfactor
The following antibodies were used in this study: mouse
MAb against human E-cadherin (HECD-1) (Shimoyama et
al.. 1989), rat MAb against a-catenin (a-18) provided by Drs
S Tsukita and A Nagafuchi, rabbit polyclonal antibody
against A-catenin provided by Dr S Shibamoto, mouse MAb
against human EGFR (Ab-1, Oncogene Science, Mineola,
NY, USA) and mouse MAb against phosphotyrosine (4GI0,
Upstate Biotechnology, Lake Placid, NY. USA) Human
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Immnofluorescent cytochemistry
Cells cultured on 15 mm coverslips were fixed with 3.5%
paraformaldehyde in phosphate-buffered saline (PBS) for
30min at 4C, extracted with methanol at -20C for 10 mm,
rinsed with 0.01 M Tris-buffered saline (pH 7.2) containing
1 mM calcium chloride (TBS-Ca), treated with 5% skimmed
milk, or 1% bovine serum albumin for phosphotyrosine for
30mmm and subsequently incubated with HECD-1 or 4G10
for 60 min at room temperature. After extensive washing
with TBS-Ca, the samples were incubated with fluorescein
isothiocyanate (FITC)-labelled anti-mouse IgG (Cappel, Dur-
ham, NC, USA). After washing, the preparations were
mounted with Permafluor aqueous mounting medium
(Immunon, Pittsburgh, PA, USA) to prevent bleaching. They
were examined and photographed using a phase-contrast
fluorescence microscope (Olympus, Tokyo, Japan). To
examine the effect of EGF, cells were incubated in the
presence of 30ngml-' EGF with or without 0.5mm
vanadate or 0.2 jag ml- ' herbimycin A for 30min. In order to
induce extensive morphological changes, treatment with EGF
was continued for 24h. The ceIls were then subjected to
immunofluorescent cytochemistry as described above.
Immunoprecipitation
To detect E-cadherin and cadherin-associated proteins by
immunoprecipitation, 4 x 106 cells were lysed with 2 ml of
the extraction buffer (1 % Triton X-100, 1% Nonidet P-40,
1 mm calcium chloride, 2 mM phenylmethylsulphonyl fluoride
and 20 jg ml-' leupeptin in 50mM TBS pH 7.4) and cent-
rifuged at 12 000 r.p.m. for 30 min. The supernatant was
preabsorbed by incubation with 50 id of protein A-
Sepharose (Pharmacia LKB Biotechnology, Uppsala,
Sweden) for 30 min. After removing the beads, the solution
was mixed with 50 jg ofHECD-I for 2 h and then incubated
with 100pi of protein A-Sepharose for 2 h. The beads were
collected by centrifigation, washed five times with extracton
buffer, then suspended in 100pid of SDS sample buffer con-
taining 5% 2-mercaptoethanoL and boiled for 5 min. The
released materials were analysed by immunoblotting. Stimu-
lation by EGF was performed in the same way as
immunofluorescent cytochemistry.
Immunoblotting
Immunoblot analysis was carried out as described previously
(Nose and Takeichi, 1986) with some modifications. Briefly,
1 x 106 cells were lysed with 100pl of sample buffer contain-
ing 2% SDS. After boiling for 5 min in the presence of 5%
2-mercaptoethanol, lOI of the sample was subjected to
separation on a polyacrylamide gradient gel SDS-PAGE
4/20 (Daiichi Pure ChemicaL Tokyo, Japan). The fraction-
ated proteins were transferred onto a nitrocelulose mem-
brane. After blocking for 1 h with 5% skimmed mil or with
% bovine serum albumin for phosphotyrosine, the mem-
branes were incubated with HECD-l or other antibodies for
1 h at room teprature. Vmualisation was performed usng
an Immune-Blot Assay Kit (Bio-Rad, Hercules, CA,
USA).
Cell aggregation assay
Cadhern-dependent cell aggregation was assayed as des-
cribed before (Takeichi, 1977). Briefly, cells were treated with
0.01% crystallised trypsin in the prese of 0.5 mM calcium
chloride at 3TC for 20 mi, and then washed with Ca2+ and
Mg2+- free 4-(2-hydroxyethyl)--piperaneethanesulphonic
acid-buffered (pH 7.4) Hankls' balanced salt solution to
obtain single-cell suspensions. Cells suspended in this solu-
tion containing 0.3 mM calcium chloride with or without
30 ng ml'- EGF were placed in wells of a 24-well plate and
pic depiiu m faior- cd-cdadin
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incubated to allow aggregation for 30min at 37C on a
gyratory shaker rotating at 80r.p.m. The aggregates were
observed and photographed using a phase-contrast micro-
scope (Olympus, Tokyo, Japan). For further culturing, cells
were collected and resuspended in 2ml of DH5 with the
same concentration of EGF, put on the 3.5 cm plastic dish
coated with 1% agar to prevent cells adhering to the bottom
and incubated in 5% carbon dioxide incubator for 48 h.
Cell dissociation assay
Cell dissociation was measured quantitatively using the
Transwell system (pore size 12pm) (Costar, Cambridge,
MA, USA), as previously described (Doli et al., 1993k'
Approxiatly I x 10i cells were trypsinised and suspn
in 5001d of DH5. The cell suspensions were then applied to
the upper compartment, and the lower compartment was
filled with 1500 jd of DH5. After incubation for 24h, the
upper compartment was placed into a ftesh lower compart-
ment and the media in both we exchang with DH5
containing graded doses (0-30ngml-') ofEGF. Following a
48 h incubation, the cells, which passed through the micro-
pore membrane and adhered to the bottom of the lower
compartment were fixed with 10% formaldehyde, stained
with haematoxylin and counted using a microscope.
Invasion assay with organotypic raft culture
In vitro tumour invasiveness was evaluated using organotypic
raft culture, as previously described (Doki et al., 1993).
Briefly, in a 12-well plate, 2.5 x 105 tumour cells resuspended
in 1 ml ofmedium were seeded on the gel of DH5 coniing
1.0mgml-' type I collagen (Cell Matrix Type I-A, Nitta
Gelatin, Osaka, Japan) and 3 x 10 human hmg fibroblasts
of the MRC-5 cell line (provided by the Japanese Canr
Research Resources Bankc). After inubation for 24h, gels
were detached from the well, incubated for 24h to induce
contraction of the gel and floated at the air-fluid interface
on stainlestel grids plaiced into 100mm culture dishes.
Cells were refed every other day with 10ml of DH medium
containing 10% fetal calf serum with or without EGF at
lOngml'- and 30zgml- in HECD-1. After 14 days, the
composite gels were fixed with 10% formaldehyde, paraffin
embedded, sectioned and stained with hatoxylin and
eosin. They were obsrved and photographed using a micro-
scope.
RedIs
Morphological changes by EGF in two-dim al culture
Immunoblot analysis using total cell lysates rvealed that the
TE-2R cells expressed a consideable amount of EGFR,
although the level was found to be lower than in A431 cels
(Figure la). Upon addition of EGF, autophosphorylation of
the EGFR was apparent by immunoblot analysis using an
anti-phosphotyrosine antibody (Figure lb). We then examin-
ed the effect of EGF on cell growth and found that EGF
slightly suppressed growth in a dose-dependent manner
(0-l00ngml-'). After 7 days' incubation, a mimum 30%
suppression of growth was observed in the presence of
100ngml-' EGF as compared with control untreated cells
(data not shown). TE-2R cells expressed a large amount of
E-cadherin (Figure Ic) and also expressed both a- and 1-
catenin, which bind the cytoplamic domain of cadherin and
regulate cadherin function (Figure Id and e).
A striking morphologial change in TE-2R was observed
after 24h of exposure to EGF. More than 10ngml-' EGF
led to an extensive change in cellular morphology, but at
concentrations greater than 100 ngml-' EGF appeared
slightly toxic for cell growth. Therefore, in the following
assay, we chose to treat cells with 30 ng ml-' unle other-
wise indicated. TE-2R cells originally exhibited a round cell
shape and formed cobblestone-patterned colonies. Following,,Efbd depkkrmW viwafacbx oncd-cd adhesion
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EGF treatment, TE-2R cells exhibited a fibroblastic shape
and a dispersion of colony formation (Figure 2a and b). To
examine whether this alteration of cellular morphology is
linked with the action of the tyrosine kinase, we tested the
effect of vanadate, an inhibitor of phosphotyrosyl protein
phosphatases that consequently potentiates tyrosine phos-
phorylation (Brown and Gorden, 1986). Medium containing
EGF and 0.5 mM vanadate was added to TE-2R cells and led
to a further alteration in cell morphology (Figure 2c). We
a b
next examined the effect of herbimycin A, a specific inhibitor
of tyrosine kinase (Uehara et al., 1988). The addition of
0.2 Lg ml-' herbimycin A inhibited the change in cell mor-
phology induced by EGF (Figure 2d).
To investigate whether this morphological change induced
by EGF involved cell-cell adhesion mediated by E-cadherin,
we stained TE-2R cells with HECD-1, an antibody for
human E-cadhenn. In the absence of EGF, the edge of
cell-cell contact sites overlapped each other with jagged
c d e
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Fugwe 1 a, Immunoblot analysis using total cell lysates of EGFR (MW = 175 kDa) b-e, Tyrosine phosphorylation 10, 30 or
60 min after treatment with (b) 30 ngml-' EGF, (c) E-cadherin (E-cad, MW = 124 kDa) (d) a-catenin (ci-cat, MW = 102 kDa) and
(e) P-catenin (>-cat, MW = 88 kDa). Lane 1, A431 cells; lanes 2, TE-2R cells; lanes 3, TE-2S cells (negative control; E-cadherin
negative clone). Molecular weight markers of 205, 116.5 and 80 kDa are indicated by bars on the left.
Fugwe 2 Effect of EGF, vanadate, and herbimycin A on cell morphology after 24 h of exposure in TE-2R cells. a, No treatment.
b, In the presence of 30 ng ml- EGF. c, In the presence of 30 ngml-' EGF and 0.5mM vanadate.d, In the presenceof 30 ng ml-'
EGF and 0.2 Lg ml' herbimycin A.
12 17 12 2 12 13 1surfaces, where E-cadherin was strongly stained (Figure 3a).
Apparent changes in E-cadherin distribution were observed
much earlier than major changes in cell morphology. After
30 min incubation with EGF. immunoreactive lines that
segregate individual cells became sharp and smooth; in addi-
tion. a small amount of E-cadherin was detected in the apical
surface of the cell membrane (Figure 3b). Treatment of cells
with vanadate enhanced the staining pattern whereby more
E-cadherin was observed in the apical cell surface. Moreover.
intercellular adhesions were partially disrupted and E-
cadherin was stained as a non-continuous line (Figure 3c).
Cells treated with EGF and herbimycin A displayed the same
E-cadherin localisation as untreated cells (Figure 3d). After
Eftd o epdemal_owt f!ador on cd-cd adhesion
H Shiza4u et al
253
incubation for 24 h with EGF, most E-cadhenn existed on
the apical surface and a small amount remained in the
cell-cell contact sites (Figure 3e). Although an extensive
alteration of E-cadhenrn localisation was induced by EGF,
the total fluorescence of E-cadherin staining appeared to be
at similar levels throughout these expenrments.
We also performed immunofluorescent staining utilising
4G10, an antibody against phosphotyrosine residues. We did
not observe any obvious differences after 24 h treatment with
EGF. However, in the early phase of EGF treatment, signifi-
cant changes were observed. Figure 3f demonstrates that in
untreated TE-2R cells phosphotyrosine staining was weakly
detected in focal contacts. In EGF-treated cells, phospho-Effect d epidrmal wth facor on cl-cd adhesion
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tyrosine stained predominantly in sites of cell-cell contact
and not in sites of focal contact (Figure 3g). In the presence
of both EGF and vanadate. phosphotyrosine staining in sites
of cell-cell contact was enhanced (Figure 3h). In contrast.
addition of herbimycin A to EGF-treated cells led to a
phosphotyrosine pattern that resembled untreated cells
(Figure 3i).
Effect ofEGF on cell adhesive capacitY
The cell-cell binding activity was evaluated by both cell
aggregation and dissociation assays. In the cell aggregation
assay, cell aggregates were observed in TE-2R cell culture
after a 30 min incubation period (Figure 4a). E-cadherin was
found to be responsible for this aggregation since an
antibody against E-cadherin blocked this response (Doki et
al., 1993). In the 30 min time period, EGF did not inhibit the
aggregation of TE-2R cells (Figure 4b). However, since it
took much more time to induce obvious morphological
change in two-dimensional cutlure, we extended the time in
suspension culture on agar to 48 h. Within this time penod.
the aggregates of TE-2R cells became compact with smooth
surfaces and the cells flattened and adhered tightly (Figure
4c), whereas in EGF-treated TE-2R cells such compaction
was not induced and cell remained round and loosely ad-
herent (Figure 4d).
Cell dissociation was evaluated by counting the cells that
passed through a micropore membrane after 48 h of incuba-
tion. In our previous study. the dissociation of TE-2R cells
was facilitated by disruption of cell-cell adhesion using an
E-cadherin antibody (Doki et al.. 1993). EGF also strongly
facilitated the dissociation of TE-2R cells in a dose-
dependent manner (Figure 5).
Effect ofEGF on invasion assaYs in vitro
Organotypic raft culture was performed to assess the effect of
EGF on invasiveness in vitro. TE-2R cells did not possess
invasive capacity. however cell invasion was induced upon
addition of HECD-1 (30 pg ml-') (Figure 6a and b). as
previously described (Doki et al., 1993). In the presence of
EGF (10 ng ml-'). TE-2R cells displayed invasive capacity,
although the invading cell cluster was larger and the depth of
invasion was shallower than that treated with HECD-1
(Figure 6c). In cooperation with HECD-1, EGF facilitated
invasion most strongly, and disruption of stratified
epithelium was also observed (Figure 6d).
Molecular mechanism ofdysfunction in the E-cadherin
adhesion system
Although, the effect of EGF on the E-cadherin adhesion
system was considered to be partly responsible for the mor-
phological change and down-regulation of adhesive capacity
shown in the above experiments, the molecular mechanism
remained to be elucidated. At first, we examined the amount
of E-cadhenrn and a- and P-catenin in total cell extracts by
immunoblotting. No difference was observed in the expres-
Figwe 3 Immunofluorescent staining for E-cadherin (a-e). and phosphotyrosine (f-i), in TE-2R cells. a and f, No treatment. b, h
and g, In the presence of 30 ng ml ' EGF after 30 min. e, In the presence of 30 ng ml1-' EGF after 24 h. c and h, In the presence of
30 ng ml-' EGF and 0.5 mm vanadate after 30 min. d and i. In the presence of 30 ng ml -' EGF and 0.2 ;zg ml -' herbimycin A
after 30 min.
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Figure 4 Cell aggregation assay of TE-2R cells. Aggregation after 30 min incubation a and b and on agar for 48 h c and d without
a and c or with b and d 30ngml EGF.
0
0
0 1 3 10 30
EGF (ng m-1)
Figure 5 Cell dissociation assay. The number of cells passing
through the micropore membrane in 48 h is indicated. The effect
of EGF concentration was evident in TE-2R cells (U). but not in
TE-2S cells (0) (negatise control: E-cadhenrn-negatise clone).
sion of the three molecules between EGF-treated and un-
treated TE-2R cells (Figure 7a-c).
It is well known that E-cadhenrn and a and frcatenin form
a complex which is stable against some detergents and in
co-precipitation with an E-cadherin antibody (Ozawa et al..
1989). In TE-2R cells, these three molecules were detected by
immunoblotting the immune complex of HECD-1, and it was
observed that the amount and proportion of the three mole-
cules did not change in the presence of EGF (data not
shown). Finally. we examined tyrosine phosphorylation of
the immune complex using the 4G10 antibody. which
specifically recognises phosphotyrosine residues. In the
absence of EGF. none of the components of the immune
complex was tyrosine phosphorylated. However. in the
presence of EGF. the 4G10 antibody revealed an 88 kDa
protein, which was confirmed to be P-catenin by immuno-
blotting (Figure 7d). Moreover. phosphorylation of the
88 kDa band of frcatenin was strongly enhanced by the
addition of vanadate and disappeared upon addition of her-
bimycin A to EGF-treated TE-2R cells (Figure 7d).
Discussion
The present study describes the effect that EGF has on the
E-cadherin adhesion system and the consequent effects on
cellular morphology. In the presence of EGF, TE-2R cells
displayed morphological changes including transition to a
fibroblastic cell shape and dispersed colony formation, which
was similar to that of the cells without E-cadherin (Doki et
al.. 1993). Also. in long-term aggregation and cell dissocia-
tion assays. the adhesive capacity of TE-2R cells was sup-
pressed by EGF. These results suggest that, in the presence
of EGF. TE-2R cells lose their characteristic morphology,
accompanied by changes to E-cadherin expression.
Striking changes were not observed, however, in short-term
aggregation or morphology assays dunrng the first 30 min of
exposure to EGF. and it took more than 24 h to induce
obvious changes. The process of forming complete cell-cell
adhesion by cadherin was explained by Takeichi (1977) as
follows. At first. cadherins are distributed over the whole cellEfkstdof_spi 71 facor on cd-cd adhesion
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Figure 6 Invasion assav of TE-2R cells in organotypic raft culture. a. No treatment. b. In the presence of 30jig mlV' HECD- . c.
In the presence of lOngml-' EGF. d. In the presence of lOngml-' EGF and 3Oggml-' HECD-1.
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Figue 7 Immunoblot analysis of (a) E-cadherin (E-cad, MW = 124 kDa) in total cell extracts (lanes I and 2). detergent-soluble
fraction (lanes Is and 2s) and insoluble fraction (lane li and 2i), (b) m-catenin in total cell extracts (m-cat, MW = 102 kDa). (c) A-catenin in total cell extracts (frcat, MW = 88 kDa) and (d) tyrosine phosphorylation in immunoprecipitated E-cadherin,catenin
complexes of TE-2R cells. Lane 1, no treatment; lane 2, in the presence of 30 ng ml-' EGF; lane 3, in the presence of 30 ngmlP '
EGF and 0.5mm vanadate; lane 4, in the presence of 30ngml-' EGF and 0.2pggml-' herbimycin A.
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surface in isolated cells. When two cells come into contact,
they are bound by cadherin at one point. Thereafter, other
cadherins concentrate at this point, the shape of the cells is
deformed and a large area of cell-cell contact forms. This
last phenomenon is designated compaction and requires
catenins and association with the cytoskeleton. Short-term
aggregation assays mainly detect the first step in the cadherin
reaction, and the degree of aggregation depends on the
number of cadherin molecules'. EGF suppressed not short-
term aggregation but long-term compaction, therefore EGF
was considered to affect some aspect of this sequence of
events. This assumption is consistent with the observation
that E-cadherin is distributed over the whole cell surface after
24 h of exposure to EGF.
EGF transmits its signal to the cell via the EGFR, a
member of the receptor-type tyrosine kinase family, which is
activated by autophosphorylation of its tyrosine residues.
Both EGFR and E-cadherin are known to localise in inter-
cellular adherence junctions (Fukuyama and Shimizu. 1991).
Immunoblotting and immunostaining by a phosphotyrosine
antibody revealed that EGFR was located at cell contact
sites and was strongly autophosphorylated by stimulation
with EGF. This led us to believe that the tyrosine kinase
activity of EGFR was very closely associated with the E-
cadherin adhesion system. In fact. vanadate. a tyrosine phos-
phatase inhibitor. potentiated the effect of EGF on the E-
cadherin adhesion system. In contrast. herbimycin A. a tyro-
sine kinase inhibitor. reduced this effect. These results imply
that tyrosine phosphorylation of a member of the E-cadherin
system is involved in the action of EGF. It has been shown
that activation of EGFR leads to phosphorylation of several
cytoskeleton-associated proteins, such as ezrin, vinculin and
spectrin (Akiyama et al., 1986; Bretscher, 1989). Although
interaction between these cytoskeletal proteins and cadhenn
is not understood. the E-cadherin adhesion system might be
phosphorylated in a similar way.
Thus. tyrosine phosphorylation of the E-cadherin system
seemed to be partly responsible for the morphological change
induced by EGF. Therefore, we examined tyrosine phos-
phorylation of E-cadherin and a- and fratenin and found
tyrosine phosphorylation ofP-catenin in EGF-treated TE-2R
cells. It has recently been reported that tyrosine phosphoryla-
tion of the cadherin catenin complex suppresses cadherin
function in vitro (Matsuyoshi et al.. 1992; Behrens et al.,
1993; Hamaguchi et al.. 1993).
Although P-catenin forms complexes with cadherin and
a-catenin. its exact role remains to be elucidated. Experi-
ments utilising cells expressing fusion proteins of cadherin
and a-catenin that lack frcatenin binding sites demonstrate
that these cells adhere to each other more tightly than cells
with normal cadherins (S Tsukita, unpublished data). 3-
Catenin might have the effect of down-regulating cadherin
function. Recently. binding between the APC tumour-
suppressor gene product and frcatenin was reported. and it
was suggested that mutation of APC might render inade-
quate the binding capacity between APC and frcatenin
(Rubinfeld et al.. 1993: Su et al.. 1993). The association
between APC and phosphorylation of frcatenin is not clear
and should be resolved in the future.
In organotypic raft culture. EGF-treated TE-2R cells
invaded the gel. Tumour invasion involves many factors,
including proteolysis and cell motility, which are stimulated
by EGF (Engstr6m 1986; Boyd. 1989; Niedbala and Sar-
torelli, 1989). In this study, we indicate the possibility that
down-regulation of E-cadherin by EGF might be another
major factor that facilitates cell invasion.
We have studied E-cadherin and m-catenin expression in
carcinomas in vivo and found that decreased expression is
significantly correlated with dedifferentiation, invasion and
metastasis (Kadowaki et al.. 1994; Matsui et al., 1994). How-
ever, some tumours. especially signet ring cell carcinomas of
the stomach, express both E-cadherin and x-catenin and
exhibit inconsistent invasion, forming dispersed colonies
(Matsui et al., 1994). Some of them have been shown to have
a mutated E-cadherin gene (Becker et al., 1994; Oda et al..
1994). but the rest are supposed to have intact E-cadherin
genes and associated proteins. On the other hand, some
diffuse types of gastric cancers, including signet ring cell
carcinomas, are known to express many unidentified proteins
with enhanced phosphorylation of tyrosine residues (Take-
shima et al., 1991). These phenomena might have some
association with tyrosine phosphorylation of P-catenin.
However. it is not known what type of tyrosine kinase can
induce the tyrosine phosphorylation of P-catenin in vivo. In
vitro, the association of EGFR was suggested in the present
study, and v-Src has been suggested in the previous studies
(Matsuyoshi et al.. 1992: Behrens et al.. 1993; Hamaguchi et
al., 1993). We observed similar morphological changes and
phosphorylation of 0-catenin in other squamous cell car-
cinomas (T-T, TTn, TE-3: authors' unpublished observation).
All of them overproduce EGFR. so that EGFR might be the
most plausible candidate in oesophageal squamous cell car-
cinoma. Furthermore, Gavrilovic et al. (1990) have reported
that TGF-c. an EGFR ligand. induces a motile fibroblast-
like phenotype in vitro. This study supports our hypothesis.
However, various growth factor receptors with tyrosine
kinase activity have been reported to be associated with
carcinogenesis and tumour progression in vivo (Ullnrch and
Schlessinger, 1990). Hepatocyte growth factor receptor is one
of them and is known to promote not only cell growth but
cell scattering (Matsumoto and Nakamura. 1992), indicating
that phosphorylation offrcatenin may be involved. Thus, the
association of growth factor signal transduction and cell
adhesion is an important problem that should be further
investigated.
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